Windy City Media Group Frontpage News
Celebrating 30 Years of Gay Lesbian Bisexual and Trans News
home search facebook twitter join
Gay News Sponsor Windy City Times 2017-03-22
DOWNLOAD ISSUE
About WCMG Publications News Index  Entertainment Features Bars & Clubs Calendar Videos Advertisers OUT! Guide    Marriage


  WINDY CITY TIMES

Community Outraged at AIDS Drug Price Increase
by Bob Roehr
2003-12-31

facebook twitter del.icio.us stumble upon digg google +1 reddit email


Abbott Laboratories quietly increased the price of ritonavir (Norvir) by 400% Dec. 4, from $1.71 to $8.57 per 100 mg pill. The protease inhibitor (PI) primarily is used in sub-therapeutic doses with other protease inhibitors to delay their clearance by the liver. That means the price increase will be felt widely.

The AIDS community has only slowly become aware of the increase and is reacting with outrage and threats of boycott.

The company has asserted that the increase is a long-overdue price adjustment and reflects the cost of past research when they had to reformulate the compound. It also is not increasing the price to state-run AIDS drug assistance programs (ADAPs).

But many observers are calling it a ploy by Abbott to increase the market share of Kaletra, its other protease inhibitor. Kaletra had been losing ground to other PIs that have recently been approved for sale. This would boost the total cost of other PIs that must use Norvir as booster.

Michael Weinstein, president of the AIDS Healthcare Foundation, noted that even while the price of Norvir was skyrocketing, the price of Kaletra, which uses Norvir to boost its potency, did not increase at all.

'This is purely a marketing ploy to push for a larger market share for Kaletra by driving providers and patients to this cheaper Abbot combination therapy,' Weinstein said. 'The HIV community as a whole should unite and speak out against Abbott's bald-faced greed.'

'Abbott is feeding like a vulture on the bones of our healthcare system,' the AIDS Treatment Activists Coalition (ATAC) said in a flyer they are distributing about the price increase (see Web site www.atac-usa.org/Abbott%20Vulture.pdf).

ATAC, in a letter to Abbott dated Dec. 22, noted that tipranavir, a promising PI under development by Boehringer Ingelheim, uses 400 mg of Norvir daily. If the price increase stands and if tipranavir is approved by the FDA, its price would be about $20,000 a year, several times that of other currently available PIs.

'Abbott has changed the landscape of HIV/AIDS for the worse—is this what it wants to be known for?' asked ATAC. 'We believe that it is in the overall interests of your company to reconsider this shameful and destructive path.'

The HIV Medicine Association called on Abbott to rescind the price increase. 'It is critical that the implications of your actions on access to the majority of treatment regimens available to persons living with HIV/AIDS in the U.S. be given paramount consideration,' it wrote in a Dec. 18 letter to Abbott.

'This increase comes at a time when public programs that provide access to HIV treatment are struggling to keep costs down, and numerous ADAPs have been forced to impose eligibility and formulary restrictions and/or waiting lists.'

Howard Grossman, a physician in New York City with a large HIV practice, said in an e-mail he is 'going to refuse to have Abbott reps in my office and will try to find alternatives to any of their drugs I can.' He is asking the American Academy of HIV Medicine, where he serves as chair of the policy committee, to return funding from Abbott.

'To receive academic or financial support from Abbot Laboratories would be an insult to the many patients who this decision so greatly impacts,' Benjamin Young wrote to the company. The HIV doc and clinical instructor of medicine at the University of Colorado has rescinded any offer to lecture on behalf of the company, attend its advisory committee meetings, or support its research projects.

The London-based AIDSmap quoted one pharmaceutical company research scientist as saying, 'This isn't just an attack on competitors' pricing, it's an attack on their research strategies. Why bother investing in these areas if Abbott has effectively priced you out of the market?'

There is an unconfirmed report that the crusading New York Attorney General, Elliot Spitzer, has initiated an investigation into the price increase.

Grapefruit juice and a number of other drugs have an effect similar to Norvir in terms of slowing the liver's clearance of drugs such a PIs. But none of the alternatives have been studied and so there is no data on whether or how they might be substituted. Given Abbott's price increase, that is an area that researchers are likely to give new attention.


facebook twitter del.icio.us stumble upon digg google +1 reddit email




Windy City Media Group does not approve or necessarily agree with the views posted below.
Please do not post letters to the editor here. Please also be civil in your dialogue.
If you need to be mean, just know that the longer you stay on this page, the more you help us.


  ARTICLES YOU MIGHT LIKE

'HIV & Aging' panel at Alphawood March 22 2017-03-22
Adler president reveals HIV status 2017-03-22
World: Murder suspects nabbed, new anti-HIV drug, Japan's first trans male official 2017-03-21
Trump's budget would hurt HIV and STDs response, national non-partisan health groups say 2017-03-16
AIDS United affirms research on viral loads 2017-03-15
'HIV & Aging' panel March 22 2017-03-15
AIDS care nurse's life is rendered in comic-book form 2017-03-15
Art AIDS hosts Karen Finley event 2017-03-15
AIDS/LifeCycle Team CÜR St. Patty's Day fundraiser 2017-03-15
National roundup: #ProtectTransWomen, Black AIDS Institute, soccer incident 2017-03-14
'Out at the CHM' event examines art, AIDS and activism 2017-03-12
Art AIDS America Closing Weekend events April 1, 2 2017-03-10
LGBTs and people living with HIV have much at stake in ACA reform debate 2017-03-08
OUT Chicago live broadcast at Art AIDS America March 12 2017-03-08
HIV and Aging at Alphawood Gallery March 22 2017-03-07
'Art, AIDS and Activism' March 3 2017-03-01
OUT Chicago broadcast from the Art AIDS America Exhibit March 12 2017-02-28
Out at CHM to explore Art, AIDS and Activism 2017-02-24
Elizabeth Taylor AIDS Foundation does tribute video on her 85th Birthday 2017-02-23
At Midwest BLGT and Ally College Conference, AIDS activist talks Trump-era organizing 2017-02-22
LETTERS Lives at stake 2017-02-22
Kevin's Room notes 15 years of Black HIV/AIDS awareness 2017-02-22
LGBTQs join "A Day Without Immigrants," condemn raids on immigrant communities 2017-02-16
Activist Maxx Boykin on HIV/AIDS fight and new challenges 2017-02-15
AIDS film kicks off Legacy LIVE series 2017-02-15
Howard Brown marks nat'l Black HIV/AIDS day with panel 2017-02-14
Battling Chicago's HIV/AIDS disparities 2017-02-13
Lambda Legal, EEOC win settlement for healthcare worker fired for being HIV+ 2017-02-09
Johnson among Gilead recipients 2017-02-07
HIV/AIDS awareness event on Feb. 6 2017-02-01
Lambda Legal: Price would endanger health of LGBTs, people living with HIV 2017-01-18
Bill T. Jones to speak at DuSable 2017-01-18
Cartooning AIDS' at Gerber/Hart 2017-01-18
Legacy LIVE to present Short Fuse: Story of an AIDS Activist, Sotomayor's story 2017-01-14
Gilead Sciences to give $22M in grants to new HIV cure research projects 2017-01-11
Local study of injectable HIV drug launches 2017-01-11
Peter Staley to present keynote at MBLGTACC 2017 2017-01-09
ART REVIEW Art AIDS America/Chicago 2017-01-04
Cook County Health & Hospitals part of study to test new HIV-prevention medication 2016-12-28
Heartland official speaks on testing, PrEP outreach 2016-12-28
 



Copyright © 2017 Windy City Media Group. All rights reserved.
Reprint by permission only. PDFs for back issues are downloadable from
our online archives. Single copies of back issues in print form are
available for $4 per issue, older than one month for $6 if available,
by check to the mailing address listed below.

Return postage must accompany all manuscripts, drawings, and
photographs submitted if they are to be returned, and no
responsibility may be assumed for unsolicited materials.
All rights to letters, art and photos sent to Nightspots
(Chicago GLBT Nightlife News) and Windy City Times (a Chicago
Gay and Lesbian News and Feature Publication) will be treated
as unconditionally assigned for publication purposes and as such,
subject to editing and comment. The opinions expressed by the
columnists, cartoonists, letter writers, and commentators are
their own and do not necessarily reflect the position of Nightspots
(Chicago GLBT Nightlife News) and Windy City Times (a Chicago Gay,
Lesbian, Bisexual and Transegender News and Feature Publication).

The appearance of a name, image or photo of a person or group in
Nightspots (Chicago GLBT Nightlife News) and Windy City Times
(a Chicago Gay, Lesbian, Bisexual and Transgender News and Feature
Publication) does not indicate the sexual orientation of such
individuals or groups. While we encourage readers to support the
advertisers who make this newspaper possible, Nightspots (Chicago
GLBT Nightlife News) and Windy City Times (a Chicago Gay, Lesbian
News and Feature Publication) cannot accept responsibility for
any advertising claims or promotions.

 

 

 

TRENDINGBREAKINGPHOTOS

Sponsor
Sponsor
Sponsor
Sponsor
Sponsor


 

Sponsor


Sponsor

About WCMG Publications News Index  Entertainment Features Bars & Clubs Calendar Videos Advertisers OUT! Guide    Marriage



About WCMG      Contact Us      Online Front  Page      Windy City  Times      Nightspots      OUT! Guide     
Identity      BLACKlines      En La Vida      Archives      Subscriptions      Distribution      Windy City Queercast     
Queercast Archives      Advertising  Rates      Deadlines      Advanced Search     
Press  Releases      Event Photos      Join WCMG  Email List      Email Blast     
Upcoming Events      Todays Events      Ongoing Events      Post an Event      Bar Guide      Community Groups      In Memoriam      Outguide Categories      Outguide Advertisers      Search Outguide      Travel      Dining Out      Blogs      Spotlight  Video     
Classifieds      Real Estate      Place a  Classified     

Windy City Media Group produces Windy City Queercast, & publishes Windy City Times,
The Weekly Voice of the Gay, Lesbian, Bisexual and Trans Community,
Nightspots, Out! Resource Guide, and Identity.
5315 N. Clark St. #192, Chicago, IL 60640-2113 • PH (773) 871-7610 • FAX (773) 871-7609.